Subscribe to Newsletter

Search

Reset Filter
You have a filtered search result

333 search results for ‘*’

Business & Regulation Profession

Change Is the Only Constant

| Angus Stewart | 9 min read

Diversity, support networks, and unexpected journeys: what nine years of C&G biz wisdom can teach us

Discovery & Development Drug Discovery

The Catalan Connection

| Angus Stewart | 7 min read

Based in Barcelona and Belgium, this startup company is bringing small molecules to the fight against X-linked leukodystrophy

Discovery & Development Analytical Science

The Cutting Edge of Biopharma Analytics

| Angus Stewart | 7 min read

How can new analytical tech help biopharma manufacturers?

Business & Regulation Digital Technologies

Keep Connected

| Angus Stewart | 11 min read

Nuvolo was crowned the grand winner of the 2021 Innovation Awards. We find out what makes their software so special.

Business & Regulation Trends & Forecasts

An Eye on the Higher Branches

| Angus Stewart | 4 min read

Can cell and gene therapy help bring an end to rare eye diseases?

Discovery & Development Clinical Trials

We are the Resensitizers

| Angus Stewart | 8 min read

The cell cycle can be used to shut down cancer’s survival mechanisms, but what does it take to turn that knowledge into a medicine?

Business & Regulation Trends & Forecasts

The Headset Mindset

| Angus Stewart | 8 min read

As the ATMP hiring market struggles through the Great Resignation, can VR take us back to the future?

Business & Regulation Business Practice

Staying Engaged

| Maryam Mahdi | 3 min read

Ashfield Engage’s Ian Riches explains how companies can make patient engagement a priority.

Business & Regulation Profession

Dreams, Chimps, and Chocolate Cakes

| Angus Stewart | 9 min read

ISCT’s new president talks platforms, regulation, and knowledge-transfer for the next generation

Manufacture Facilities

The Grand Challenge: Oligonucleotides Under the Microscope

| Maryam Mahdi | 5 min read

How can pharma companies ensure the future success of the oligonucleotide therapeutic market?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register